VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SONM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SONMDNA X, Inc.
$5.79$73M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSONMBalance Sheet

DNA X, Inc. (SONM) Balance Sheet

9Y historyFree accessUpdated daily

Total assets have experienced a severe decline from $56.0 million in 2023Q4 to just $4.8 million in 2026Q1, reflecting a rapid depletion of the company's resource base.

SONM Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Total Current Assets3.3M28.91M32.16M43.79M43.63M35.69M45.57M47.34M63.87M27.37M
Cash & Short-Term Investments1.2M1.3M5.34M9.4M13.21M11.23M22.14M11.3M13.05M1.58M
Cash Only1.2M1.3M5.34M9.4M13.21M11.23M22.14M11.3M13.05M1.58M
Short-Term Investments0000000000
Accounts Receivable0011.64M26.27M24.75M14.75M5.11M11.46M21.44M12.16M
Days Sales Outstanding-127.46-72.87102.39129.3698.6629.1735.9857.6875.21
Inventory0010.62M6.52M3.91M5.54M11.34M19.53M21.83M8.98M
Days Inventory Outstanding-468.6-80.1332.0124.5242.0284.8887.2190.9984.69
Other Current Assets2.11M27.61M4.56M935K770K2.53M2.81M2.73M5.82M3.98M
Total Non-Current Assets1.53M14.99M7.57M12.26M10.05M5.4M4.74M8.12M3.48M2.88M
Property, Plant & Equipment00227K126K234K534K843K1.44M1.07M724K
Fixed Asset Turnover-222.21x-256.82x743.11x298.41x102.19x75.91x80.62x126.67x81.53x
Goodwill0000000000
Intangible Assets0000000000
Long-Term Investments1.24M1.24M00000000
Other Non-Current Assets1.53M12.31M7.35M12.13M9.82M4.87M3.9M6.68M2.41M2.16M
Total Assets4.84M43.9M39.74M56.04M53.69M41.09M50.31M55.46M67.34M30.25M
Asset Turnover-0.53x-1.47x1.67x1.30x1.33x1.27x2.10x2.01x1.95x
Asset Growth %-115.59%10.47%-29.09%4.39%30.65%-18.33%-9.28%-17.65%122.65%-
Total Current Liabilities4.32M48.03M43.74M32.15M32.06M20.98M20.47M27.61M48.2M28.03M
Accounts Payable719K4.03M22.85M19.85M22.09M9.47M8.86M7.23M27.3M11.25M
Days Payables Outstanding-1.03K342.08172.3897.49138.5171.866.2632.3113.76106.04
Short-Term Debt1.07M5.24M00147K148K177K9.82M301K3.13M
Deferred Revenue (Current)2.15M0012K31K11K5K291K4.22M4.68M
Other Current Liabilities954K38.76M13.67M10.03M5.5M9.46M9.16M8.39M13.3M7.49M
Current Ratio0.76x0.60x0.74x1.36x1.36x1.70x2.23x1.71x1.33x0.98x
Quick Ratio0.76x0.60x0.49x1.16x1.24x1.44x1.67x1.01x0.87x0.66x
Cash Conversion Cycle430.7--19.3836.9115.3768.8847.7990.8834.9153.85
Total Non-Current Liabilities600K2.6M1.7M1.53M1.58M1.48M1.43M2.32M14.02M11.73M
Long-Term Debt0000066K185K362K13.21M7.55M
Capital Lease Obligations0000000000
Deferred Tax Liabilities600K000000000
Other Non-Current Liabilities02.6M1.7M1.53M1.58M1.41M1.24M1.96M807K4.18M
Total Liabilities4.92M50.63M45.44M33.67M33.64M22.46M21.9M29.93M62.22M39.76M
Total Debt1.07M5.24M055K213K214K362K10.18M13.51M10.69M
Net Debt-123K3.93M-5.34M-9.34M-13M-11.02M-21.78M-1.11M461K9.1M
Debt / Equity-12.92x--0.00x0.01x0.01x0.01x0.40x2.63x-
Debt / EBITDA-0.17x--0.02x----1.86x-
Net Debt / EBITDA0.02x---3.44x----0.06x-
Interest Coverage-7.06x-4.35x-1151.48x19.93x-142.33x--39.12x-15.06x2.11x-9.23x
Total Equity-83K-6.73M-5.7M22.37M20.05M18.63M28.41M25.52M5.13M-9.51M
Equity Growth %-137.91%-18.02%-125.48%11.59%7.6%-34.42%11.3%397.66%153.91%-
Book Value per Share-0.01-0.52-1.215.226.9419.6861.48137.20148.78-926.75
Total Shareholders' Equity-83K-6.73M-5.7M22.37M20.05M18.63M28.41M25.52M5.13M-9.51M
Common Stock5.74M1.23M5K43K41K19K66K20K15K1K
Retained Earnings-297.6M-304.26M-283.61M-249.96M-249.87M-234.81M-196.18M-166.25M-143.53M-144.8M
Treasury Stock0000000000
Accumulated OCI0000000000
Minority Interest0000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Imminent liquidity and solvency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Rapid Erosion of Financial Position

As reported in recent financial filings, Sonim's total assets have plummeted from $56.0 million in 2023Q4 to $4.8 million by 2026Q1, signaling a severe contraction in the company's resource base and raising significant concerns regarding the long-term viability of its current operational model.

The consistent decline in total assets alongside a persistent negative equity position suggests that the company is consuming its remaining capital to fund ongoing operations. This trajectory indicates that the business is struggling to maintain its scale, potentially leading to further asset liquidation or restructuring.

Critical Depletion of Cash Reserves

Based on the latest quarterly data, Sonim's cash reserves have dwindled to $1.3 million, a figure that appears insufficient to support sustained operations given the company's history of negative cash flow and the current ratio of 0.76, which indicates a significant liquidity shortfall.

The current ratio falling below 1.0 suggests that the company may struggle to meet its short-term obligations without external financing or asset sales. Investors should monitor the cash burn rate closely, as the current liquidity buffer provides minimal protection against operational shocks or unexpected liabilities.

Persistent Erosion of Shareholder Equity

According to historical balance sheet data, Sonim's equity has shifted from a positive $22.4 million in 2023Q4 to a negative $83,000 by 2026Q1, reflecting the cumulative impact of years of operating losses and the resulting depletion of retained earnings.

The transition into negative equity territory is a stark indicator of value destruction and suggests that the company's liabilities now exceed its total assets. This condition often precedes significant corporate restructuring or the need for dilutive equity financing to restore a positive net worth.

Leverage Dynamics Amidst Financial Distress

As evidenced by recent financial statements, Sonim's debt levels have fluctuated, with $1.1 million in debt reported in 2026Q1, which, while modest in absolute terms, represents a significant burden for a company with minimal cash and a history of negative earnings.

The presence of debt in the context of negative equity and contracting assets suggests that the company's ability to service its obligations is highly precarious. The reliance on debt financing, even at low levels, may limit management's strategic flexibility and increase the risk of default.

SONM — Frequently Asked Questions

Quick answers to the most common questions about buying SONM stock.

What are the total assets of DNA X, Inc. (SONM)?

As of 2025, DNA X, Inc. (SONM) had total assets of $43.9M including $28.9M in current assets.

How much debt does DNA X, Inc. (SONM) have?

DNA X, Inc. (SONM) carries total debt of $5.2M, offset by $1.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of DNA X, Inc.?

DNA X, Inc. (SONM) has total shareholders' equity (book value) of $-6.7M ($-0.52 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is DNA X, Inc.'s current ratio and liquidity?

DNA X, Inc. (SONM) reported a current ratio of 0.60x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.